Journal
JOURNAL OF PEDIATRIC SURGERY
Volume 50, Issue 12, Pages 2094-2097Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.jpedsurg.2015.08.033
Keywords
Cell-free DNA; Next generation sequencing; Malignant solid tumor; Diagnosis; Surgical evaluation
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology, MEXT, of Japan [15H02567, 26861483]
- Japan Agency for Medical Research and Development, AMED
- Grants-in-Aid for Scientific Research [26861483, 15H02567] Funding Source: KAKEN
Ask authors/readers for more resources
Purpose: Our aims are to determine circulating free DNA (cfDNA) in childhood solid tumor patients who underwent surgical intervention and to analyze any relationships with clinical parameters. Methods: Fourty-four consenting children admitted with solid tumors between 2010 and 2014 were recruited. CfDNAs isolated from 0.5 mL plasma obtained before and 1-30 days after surgery were analyzed by next-generation sequencing (NGS: IonTorrent Cancer Hotspot panel) and by gene amplification analysis using a digital PCR (dPCR) platform. Results: Total amounts of cfDNA were 54-825 ng and were significantly associated with stage of disease. In cfDNA, 15 mutations or deletions (2 ALK, 2 TP53, 1 WT1, 3 CTNNB1, 1 APC, 1 KIT, 1 RET, 1 CDNK2AT, and 3 SMARCB1) were identified. In 10 neuroblastoma suspected cases, 2 showed high copy numbers of MYCN using dPCR. The positive rate in our cohort was 36%, and all of these aberrations were detected in the original tumors. None of the aberrations were detectable in cfDNA after surgery except for three cases whose tumors remained after surgery. Conclusions: These data demonstrate the feasibility and potential utility of mutation/deletion/amplification screening in cfDNA using NGS and dPCR for the detection of tumor biomarkers in children with solid tumors. These markers also have the potential utility to evaluate complete resection after surgery. (c) 2015 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available